More on RNXT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.37 |
|
|||
| Open | $2.35 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.54 | ||||
| Day Low | $2.28 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 2,092,366 | ||||
- RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
- RenovoRx publishes PK/PD data from pancreatic cancer drug trial
- RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
- RenovoRx regains Nasdaq minimum bid price compliance
- RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Form 8-K RenovoRx, Inc. For: Aug 20
- RenovoRx receives USPTO notice of allowance for RenovoCath patent
- RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment
- Form 10-Q RenovoRx, Inc. For: Jun 30
- Form 8-K/A RenovoRx, Inc. For: Aug 12
Entities mentioned with RNXT
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- S3 | View Related Stories »
- Show More...
